|Bid||2.5500 x 1300|
|Ask||2.5800 x 29200|
|Day's range||2.5000 - 2.8800|
|52-week range||0.5500 - 7.5000|
|Beta (5Y monthly)||3.19|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2022 - 14 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
LOS ANGELES & ATLANTA, March 10, 2022--COVID-19 investigational vaccine developed by City of Hope produced neutralizing antibodies and T cells with no major side effects in Phase 1 trial.